AKR1B10 and breast carcinoma: In fact, AKR1B10 activates diacylglycerol (DAG)-mediated PKC/ERK signaling in breast cancer cells (22) and promotes breast cancer metastasis via an integrin α5 and δ-catenin mediated mechanism (23).